Evommune (EVMN) stock surges as the company posts a mid-stage trial win for its experimental drug targeting atopic dermatitis ...

The results vaulted Nektar’s market value to over $1 billion amid expectations the drug might prove a challenger to widely ...

Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...

An eczema drug from Nektar Therapeutics maintained skin responses in a one-year study, meeting and in some cases exceeding ...

According to the Australasian College of Dermatologists, eczema is a chronic condition that is not curable and must be managed. Topical steroid creams are commonly prescribed to rapidly reduce ...

High-frequency wands use low-level electrical currents to kill acne-causing bacteria and reduce inflammation. At-home devices offer more convenience but less dramatic results than in-office ...

Some people with eczema may turn to moisturizers and corticosteroid creams to help prevent and calm flare-ups, but topical treatments don't always work for every patient. And, while systemic ...

Hollywood actor Matthew McConaughey opened up about his 'embarrassing' teen years in the new edition of his Lyrics of Livin', ...

‘Melania’ declines 67% at domestic box office—one week after beating its projections US snowboard star Chloe Kim calls for unity after Trump bashes teammate over immigrant crackdown Retired FBI agent ...

Topline data were announced from two phase 3 trials evaluating amlitelimab for the treatment of moderate to severe atopic dermatitis.

The newly public Evommune shared data showing that EVO301, an IL-18 targeting protein, cleared symptoms comparably to Regeneron and Sanofi’s mega-blockbuster in a mid-stage atopic dermatitis clinical ...

Rezpegaldesleukin may be an effective therapeutic option for adults with moderate to severe AD as well as those with comorbid ...